tiprankstipranks

Sam Barker Insider Profile

4 Followers
Sam Barker, Director at Lexicon Pharmaceuticals, holds 40.41K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds 79.62K shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 0.00 shares in Cadence Pharma (Ticker: CADX).
tipranks
Sam Barker

Sam Barker
Lexicon Pharmaceuticals (LXRX)
Director

Ranked #40,866 out of 97,825 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+1.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$302K
66.42%
33.58%
A breakdown of Sam Barker's holdings

Insider Roles

Lexicon Pharmaceuticals
(LXRX)
Director
Cyclacel Pharmaceuticals
(CYCC)
Director
Roles that Sam Barker holds in companies

Most Profitable Insider Trade

Stock:
Cyclacel Pharmaceuticals
(CYCC)
Rating:Informative Sell
Date:Dec 02, 2021 - Dec 02, 2022
Return:+75.00%
The most profitable trade made by Sam Barker

Sam Barker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lexicon Pharmaceuticals
May 22, 2023
Director
Uninformative Buy
$200.63K
Cyclacel Pharmaceuticals
Jul 03, 2023
Director
Uninformative Buy
$101.44K
CADX
Cadence Pharma
Mar 21, 2014
Uninformative Sell
280.00K
List of latest transactions for each holding click on a transaction to see Sam Barker's performance on stock

Sam Barker insider profile FAQ

What is the percentage of profitable transactions made by Sam Barker?
The percentage of profitable transactions made by Sam Barker is 40%.
    What is the average return per transaction made by Sam Barker?
    The average return per transaction made by Sam Barker is 1.90%.
      What stocks does Sam Barker hold?
      Sam Barker holds: LXRX, CYCC, CADX stocks.
        What was Sam Barker’s latest transaction?
        Sam Barker latest transaction was an Uninformative Buy of ―.
          What was Sam Barker's most profitable transaction?
          Sam Barker’s most profitable transaction was an Informative Sell of CYCC stock on December 2, 2021. The return on the trade was 75.00%.
            What is Sam Barker's role in Lexicon Pharmaceuticals?
            Sam Barker's role in Lexicon Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.